Oncology Venture Sweden AB announced that the company reinforces its organization by the recruitment of Claus Frisenberg Pedersen to the position as Chief Financial Officer and Chief Commercial Officer. Claus Frisenberg Pedersen will replace CFO Nikolaj Buhl Jensen, who will take a position as Senior Consultant in the management company Buhl Oncology (Buhl Krone Holding APS). Claus Frisenberg Pedersen has a strong background in developing and executing corporate strategies from a broad array of companies and industries.

Further, Frisenberg Pedersen has an extensive experience from developing financial and brand value for the companies he works with. Prior to joining Oncology Venture, Frisenberg Pedersen held the position as CEO of ECCO Shoes in Northern Europe for five years, where he was instrumental in developing ECCO's global blueprint for retail Joint Ventures, and also played a key role in re-positioning the perception of the ECCO brand in Northern Europe. In his previous career Frisenberg Pedersen was partner in the strategy consulting firm Qvartz, and as such has advised many companies and private equity firms on topics like strategy, commercialization, brand development, retail expansion, sales management and general value creation.